CME/MOC Credit

CE Accreditation Information

Target Audience

This activity is intended for physicians, physician’s assistants/associates, respiratory therapists, pharmacists, nurse practitioners, and registered nurses engaged in the care of patients with pulmonary fibrosis.

Educational Objectives

Upon completion of this activity, participants should be able to:

• Explain the pathophysiology of IPF based on the most current data
• Accurately diagnose IPF using a systematic approach
• Effectively implement key diagnostic procedures including HRCT scanning and surgical lung biopsy
• Discuss recent evidence for treatments in the management of IPF/ILD and for those post COVID-19
• Recognize genetic components of IPF
• Describe the role of lung transplantation in IPF, and the factors that affect candidacy and timing
• Provide patient lifestyle management tools which improve functional status
• Develop a comprehensive approach to the management of IPF/ILD, that includes both pharmacologic and non-pharmacologic therapies
• Provide accurate and appropriate care and counsel for patients and their families

Faculty & Program Agenda

The list of faculty, with complete titles and affiliations, will be published soon. The agenda can be found here, as well as by scrolling further down this page.

Disclosure of Conflicts of Interest

PACE requires planners, faculty, and others who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact Zoë Bubany prior to the live event.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and the Pulmonary Fibrosis Foundation.  PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

PACE designates this live activity for a maximum of 23.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 23 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 23.0 contact hours.

Pharmacy Continuing Education

PACE designates this continuing education activity for 23.0 contact hour(s) (2.3 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008073-9999-23-119-L01-P)

Type of Activity: Knowledge

Respiratory Therapists

Application has been made to the American Association for Respiratory Care (AARC) for continuing education contact hours for respiratory therapists.